LifePoint Health, Inc. (LPNT) Stock Rating Lowered by ValuEngine

LifePoint Health, Inc. (NASDAQ:LPNT) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Friday, September 1st.

Other analysts have also issued reports about the stock. Royal Bank Of Canada restated a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a research report on Wednesday, July 5th. Zacks Investment Research upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 target price on the stock in a research report on Tuesday, July 4th. BidaskClub upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. TheStreet lowered shares of LifePoint Health from a “b-” rating to a “c+” rating in a research report on Wednesday, August 16th. Finally, Morgan Stanley initiated coverage on shares of LifePoint Health in a research report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 price target on the stock. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. LifePoint Health currently has a consensus rating of “Hold” and an average target price of $66.18.

Shares of LifePoint Health (NASDAQ LPNT) opened at 56.60 on Friday. The company has a 50 day moving average price of $57.49 and a 200 day moving average price of $61.98. The firm has a market cap of $2.27 billion, a PE ratio of 12.67 and a beta of 0.85. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95.

LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.90 by $0.06. The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The business’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter last year, the firm posted $0.69 EPS. On average, analysts forecast that LifePoint Health will post $4.06 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://ledgergazette.com/2017/09/17/lifepoint-health-inc-lpnt-lowered-to-hold-at-valuengine.html.

In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of the company’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the sale, the chairman now directly owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 7.28% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Teacher Retirement System of Texas raised its position in shares of LifePoint Health by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock valued at $216,000 after purchasing an additional 9 shares during the period. US Bancorp DE raised its position in shares of LifePoint Health by 0.8% in the second quarter. US Bancorp DE now owns 1,947 shares of the company’s stock valued at $130,000 after purchasing an additional 16 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of LifePoint Health by 1.0% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,891 shares of the company’s stock valued at $396,000 after purchasing an additional 56 shares during the period. Meeder Asset Management Inc. raised its position in shares of LifePoint Health by 0.6% in the second quarter. Meeder Asset Management Inc. now owns 13,547 shares of the company’s stock valued at $909,000 after purchasing an additional 76 shares during the period. Finally, Mason Street Advisors LLC increased its position in LifePoint Health by 0.7% during the first quarter. Mason Street Advisors LLC now owns 18,870 shares of the company’s stock worth $1,236,000 after acquiring an additional 128 shares during the period. 99.53% of the stock is currently owned by hedge funds and other institutional investors.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply